Hold scientists accountable
By Richard Hayes,
The Baltimore Sun
| 01. 17. 2006
So now it's confirmed that South Korean stem cell king Hwang Woo Suk had been lying all along - not just about the illicit manner in which the women's eggs used in his experiments were obtained, but about his major claim to have successfully created clonal human embryos in the first place. He lied to the news media, the public, his government and patients hoping for cures.
I heard Mr. Hwang speak just over a year ago at a forum at the United Nations. He was lauded by the scientists present as the Galileo of stem cell research. When a reporter asked about rumors that the eggs used in his experiments had been obtained under questionable circumstances, he denied it. None of the other scientists present voiced the least concern.
If we are to learn the most important lessons from this sorry episode, we need to be aware of the broader context.
Mr. Hwang is not the first scientist to have lied or engaged in ethically questionable behavior concerning their experiments with human genes, stem cells or embryos. The new...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...